Skip to main content
. Author manuscript; available in PMC: 2016 Dec 2.
Published in final edited form as: Eur Respir J. 2016 Apr 21;47(6):1797–1808. doi: 10.1183/13993003.01469-2015

FIGURE 1.

FIGURE 1

Flow diagram and study utilisation of the subjects enrolled in the study. CBD; chronic beryllium disease; BeS: beryllium sensitisation; ND-Con: beryllium-exposed nondiseased controls; NE-Con: nonexposed nondiseased controls; BeLPT: beryllium lymphocyte proliferation test.